Plasma Betatrophin Levels in Non-alcoholic Fatty Liver Disease
The Cross Sectional Study to Investigate the Plasma Betatrophin Levels in Non-alcoholic Fatty Liver Disease and Healthy Controls
1 other identifier
observational
80
1 country
1
Brief Summary
The study searched for answers to two questions: 1-What are the plasma betatrophin levels in subjects with non-alcoholic fatty liver disease and healthy controls. 2\. Is there any relationship between plasma betatropin levels and different stage of non-alcoholic fatty liver disease 2.Is there any relationship between plasma betatropin levels and metabolic parameters in subjects with non-alcoholic fatty liver disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2009
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2014
CompletedFirst Submitted
Initial submission to the registry
June 22, 2014
CompletedFirst Posted
Study publicly available on registry
June 27, 2014
CompletedJune 27, 2014
May 1, 2014
4 years
June 22, 2014
June 25, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Plasma betatrophin levels in subjects with non-alcoholic fatty liver disease and healthy controls.
6 months
Study Arms (2)
Non-alcoholic Fatty Liver Disese
no treatment
healthy controls
no treatment
Eligibility Criteria
Outpatient clinics of gastroenterology
You may qualify if:
- Patients with biopsy proven non-alcoholic fatty liver disease
You may not qualify if:
- Taking any drugs
- \>20 gr/day alcohol consumption
- chronic metabolic diseases
- morbid obesity
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gulhane School of Medicine Department of Endocrinology and Metabolism
Ankara, 06018, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
June 22, 2014
First Posted
June 27, 2014
Study Start
June 1, 2009
Primary Completion
June 1, 2013
Study Completion
February 1, 2014
Last Updated
June 27, 2014
Record last verified: 2014-05